XML 79 R58.htm IDEA: XBRL DOCUMENT
v3.10.0.1

COMMITMENTS AND CONTINGENCIES (Details) |  |  |  |  | 6 Months Ended |  |
--- | --- | --- | --- | --- | --- | --- | ---
Mar. 09, 2017 EUR (€) | Oct. 23, 2016 patent | Apr. 19, 2016 inter_partes_review product patent | Mar. 09, 2016 EUR (€) | Jun. 30, 2018 lawsuit | Jan. 11, 2017 subsidiary | Nov. 02, 2015 subsidiary
Loss Contingencies [Line Items] |  |  |  |  |  |  |
Number of lawsuits that if settled could have a material adverse impact on net income or cash flows | lawsuit |  |  |  |  | 1 |  |
Edwards Lifesciences vs Boston Scientific Patent Lawsuits |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |
Number of products involved in patent infringement | product |  |  | 5 |  |  |  |
Inter partes review requests | inter_partes_review |  |  | 3 |  |  |  |
Edwards Lifesciences vs Boston Scientific Patent Lawsuits | Boston Scientific |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |
Payment of bond for each patent to enforce an injunction against sales in Germany (in euros) | € | € 90,000,000 |  |  |  |  |  |
Number of subsidiaries in litigation | subsidiary |  |  |  |  |  | 2 | 2
Number of patents allegedly infringed | patent |  |  | 8 |  |  |  |
Edwards Lifesciences vs Boston Scientific Patent Lawsuits | Boston Scientific | Europe |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |
Number of subsidiaries in litigation | subsidiary |  |  |  |  |  |  | 3
Edwards Lifesciences vs Boston Scientific Patent Lawsuits | Edwards Lifesciences |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |
Payment of bond for each patent to enforce an injunction against sales in Germany (in euros) | € |  |  |  | € 10,000,000 |  |  |
Edwards Lifesciences vs Boston Scientific Patent Lawsuits | Edwards Lifesciences PVT, Inc. and Edwards Lifesciences Inc. |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |
Number of patents allegedly infringed | patent |  | 2 |  |  |  |  |

X
- Definition Loss Contingency, Bond Payment Required To Enforce Injunction Against Sales Related To Patent Infringement + References No definition available. + Details
Name: | ew_LossContingencyBondPaymentRequiredToEnforceInjunctionAgainstSalesRelatedToPatentInfringement
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number + References No definition available. + Details
Name: | ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber
Namespace Prefix: | ew_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss Contingency, Inter Partes Review Request, Number + References No definition available. + Details
Name: | ew_LossContingencyInterPartesReviewRequestNumber
Namespace Prefix: | ew_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss Contingency, Number of Products Involved in Patent Infringement + References No definition available. + Details
Name: | ew_LossContingencyNumberofProductsInvolvedinPatentInfringement
Namespace Prefix: | ew_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss Contingency, Number of Subsidiaries in Litigation + References No definition available. + Details
Name: | ew_LossContingencyNumberofSubsidiariesinLitigation
Namespace Prefix: | ew_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of another entity's patents that the entity has allegedly infringed. + References No definition available. + Details
Name: | us-gaap_LossContingencyPatentsAllegedlyInfringedNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_LitigationCaseAxis=ew_EdwardsLifesciencesvsBostonScientificPatentLawsuitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=ew_BostonScientificCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_EuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=ew_EdwardsLifesciencesCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=ew_EdwardsLifesciencesPVTInc.AndEdwardsLifesciencesInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |